Journal
EMERGING INFECTIOUS DISEASES
Volume 23, Issue 2, Pages 308-311Publisher
CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2302.160505
Keywords
-
Categories
Funding
- Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), USA
- NIH Medical Research Scholars Program
- NIH
Ask authors/readers for more resources
Of 150,000 new coccidioidomycosis infections that occur annually in the United States, approximate to 1% disseminate; one third of those cases are fatal. Immunocompromised hosts have higher rates of dissemination. We identified 8 patients with disseminated coccidioidomycosis who had defects in the interleukin-12/interferon-gamma and STAT3 axes, indicating that these are critical host defense pathways.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available